Effectiveness of Physical Therapy for Pain Relief in Footballers With Muscle Injuries: a Prospective Study

Sponsor
University of Palermo (Other)
Overall Status
Completed
CT.gov ID
NCT06018779
Collaborator
(none)
31
1
2
7.4
4.2

Study Details

Study Description

Brief Summary

The objective of this study was to evaluate the efficacy of cryoultrasound therapy versus diathermy in combination with high-intensity laser therapy for pain relief in male professional soccer players with muscle injuries. The main questions it intends to answer are:

• Is this combination of treatments effective in these patients in terms of pain relief?

Participants will receive a rehabilitation treatment consisting of cryo-ultrasound therapy and high intensity laser. Researchers will compare the group of participants, called the treatment group, with a control group to see if:

• Is the combined treatment of cryoultrasound therapy and high intensity laser more effective in these patients than the combination of diathermy and high intensity laser?

Condition or Disease Intervention/Treatment Phase
  • Other: Cryoultrasound therapy plus high-intensity laser therapy
  • Other: diathermy plus high-intensity laser therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Cryo Plus Ultrasound Therapy Versus Diathermy in Combination With High-intensity Laser Therapy for Pain Relief in Footballers With Muscle Injuries: a Prospective Study
Actual Study Start Date :
Sep 1, 2022
Actual Primary Completion Date :
Mar 13, 2023
Actual Study Completion Date :
Apr 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A

Group A will include patients who will receive a rehabilitation treatment consisting of: cryo-ultrasound therapy and high-intensity laser therapy

Other: Cryoultrasound therapy plus high-intensity laser therapy
Group A received a daily rehabilitation treatment lasting 10 sessions for 10 consecutive sessions, consisting of high-intensity laser therapy and cryo-sound therapy.

Placebo Comparator: Group B

Group B will include patients who will receive a rehabilitation treatment consisting of: cryo-ultrasound therapy and diathermy

Other: diathermy plus high-intensity laser therapy
Group B received a daily rehabilitation treatment lasting 10 sessions for 10 consecutive sessions, consisting of high-intensity laser therapy and diathermy.

Outcome Measures

Primary Outcome Measures

  1. entity of the pain [2 weeks]

    numerical rating scale; the total score ranges from 0 to 10, with higher scores indicating more pain.

Secondary Outcome Measures

  1. size of the muscle tear [2 weeks]

    measurement in centimeters by ultrasound.

  2. frequency of relapses [3 months after the injury]

    number of relapses

  3. return to play [3 months after the injury]

    number of days

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 21 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age 18-21 years;

  • professional footballer in a competitive club;

  • presence of a grade III A muscle lesion, according to the Mueller-Wohlfart classification, confirmed by ultrasound examination and occurring during sports activity at least 5 days before inclusion in the present study;

  • no previous muscle injuries in the last 6 months;

  • signature of the written informed consent for participating in the study.

Exclusion Criteria:
  • previous muscle injuries or bone fractures of the lower limbs in the last 6 months;

  • knee instability due to previous rupture of knee ligaments;

  • active neoplastic or infectious diseases;

  • congenital anomalies of the lower limbs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Functional Recovery and Rehabilitation Unit of the A.O.U.P. Paolo Giaccone Palermo Italy 90127

Sponsors and Collaborators

  • University of Palermo

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof.ssa Giulia Letizia Mauro, Professor, University of Palermo
ClinicalTrials.gov Identifier:
NCT06018779
Other Study ID Numbers:
  • MFR0032023
First Posted:
Aug 31, 2023
Last Update Posted:
Aug 31, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 31, 2023